CuidaTEXT for Alzheimer's Disease
(CuidaTEXT R01 Trial)
Trial Summary
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on caregiver support through text messaging, so it's unlikely that medication changes are required.
What data supports the effectiveness of the treatment CuidaTEXT for Alzheimer's Disease?
The research highlights that technological solutions, like digital devices and apps, can help manage Alzheimer's symptoms by improving mood, memory, and daily activities. These tools show promise in enhancing the quality of life for patients and caregivers, suggesting that similar approaches in CuidaTEXT could be effective.12345
How is the treatment CuidaTEXT for Alzheimer's disease different from other treatments?
What is the purpose of this trial?
The goal of this randomized clinical trial it to test the efficacy of CuidaTEXT, the first Alzheimer's disease and Related Dementias (ADRD) caregiver support intervention to capitalize on text messaging, among Latinos.Researchers will compare those who receive the CuidaTEXT intervention to those who do not receive the intervention to see if CuidaTEXT effects Latino caregiver stressors and their negative consequences .Participants will receive a variety of text messages, from automatic to keyword-drive, regarding ADRD education, social support, self-care, ADRD care management, and behavioral symptoms. Participants will also complete measures regarding depressive symptoms, coping, behavioral symptoms, and preparedness for caregiving.
Research Team
Jaime Perales Puchalt, PhD, MPH
Principal Investigator
University of Kansas Medical Center
Eligibility Criteria
This trial is for Latino caregivers over 18 years old who are providing hands-on care to a relative diagnosed with Alzheimer's or related dementia, indicated by an AD-8 score ≥2. Participants must have some depressive symptoms (CESD-10 score ≥7), be able to read and write, use text messaging weekly on their own cell phone, and speak Spanish or English.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the CuidaTEXT intervention, which includes a variety of text messages regarding ADRD education, social support, self-care, ADRD care management, and behavioral symptoms
Follow-up
Participants are monitored for changes in caregiver depressive symptoms and behavioral distress symptoms
Waitlist Control
Participants in the control group are offered the opportunity to start CuidaTEXT after their 7-month follow-up assessment
Treatment Details
Interventions
- CuidaTEXT
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Kansas Medical Center
Lead Sponsor
National Institute on Aging (NIA)
Collaborator
University of Puerto Rico
Collaborator
Icahn School of Medicine at Mount Sinai
Collaborator
University of Miami
Collaborator